Drug Approval | August 11, 2025
Shilpa Medicare receives approval of NorUDCA tablets for treatment of NAFLD in India
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
This marks the fourth acquisition by Corona Remedies from multinational corporations
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The company’s largest center for medical device applications, serving the entire Asian market
To streamline complex medical writing workflows with GenAI
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Subscribe To Our Newsletter & Stay Updated
